11995 results for "safefccoins Visit Buyfc26coins.com for latest FC 26 coins news..zl62"

in 15.56 milliseconds.

• Data Access Committee for study Positive Selection in Peruvians from Three Ecological Regions

  Dac EGAC00001002414

• Coloured Project - Lankheet et al

  The data is for non-commercial use only.

  Dac EGAC50000000240

• The Data Access Committee for Human Olfactory Mucosa Cells (DAC HOM) at UEF

  Dac EGAC00001003404

• DAC for scRNA-seq and scp-MS data on human bone marrow

  Dac EGAC00001003505

• A machine learning classifier for DNA repair defects using plasma DNA

  Study EGAS00001007006

• Initial cohort of 500 solid tumors screened for Basket of Baskets

  Study EGAS00001005893

• Searching for genetic modulators of the phenotypic heterogeneity in Brugada Syndrome

  Study EGAS00001005848

• DAC_MATCH-R molecular driver

  Data access committee for MATCH-R molecular driver study

  Dac EGAC50000000335

• human HYPOMAP

  Data access for HYPOMAP raw sequence data and result data objects

  Dac EGAC50000000410

• This DAC will review all requests for data related to the dataset: EGAD00001015613.

  Dac EGAC00001003562

• CITE-seq for peripheral blood samples of 5 breast cancer patients

  Study EGAS00001006241

• DAC for DNA methylation data (iMED, BCG prime, and 500FG)

  Dac EGAC00001003534

• human biopsies

  DAC for human samples derived from biopsies from patients with hydrocephaly.

  Dac EGAC50000000625

• Validation study of genome-wide polygenic score for body mass index in South Asians

  Dac EGAC00001003593

• CoV2 challenge data

  Repository containing the transcriptomic data for the CoV2 challenge study

  Dac EGAC50000000391

• H3N2 challenge data

  Repository containing the transcriptomic data for the H3N3 challenge study

  Dac EGAC50000000379

• Validation of cfDNA fragmentome analyses for early detection of liver cancer

  Study EGAS00001008111

• Exome

  Exome Seq for EGAS00001001845

  Dataset EGAD00001002160

• NHLBI's Collection of Datasets for General Research Use (Public Posting of Genomic Summary Results: Allowed)

  This collection contains all of NHLBI's authorized individual-level genomic datasets currently in dbGaP that are approved for General Research Use (GRU) and have no further limitations beyond those outlined in the model Data Use Certification Agreement. Genomic Summary Results (GSR) sharing is allowed (unrestricted) or not applicable. To request access to this study collection, select phs003132 in the dbGaP Authorized Access System.

  Study phs003132

• MicroRNA Biomarkers for Prediction of Preeclampsia

  Maternal serum was collected between 17-28 weeks gestation. Samples were obtained from the high-risk Placental Study at the University of California, San Diego (n=48) and from the average-risk Proteomic Assessment of Preterm Risk (PAPR) Study at Sera Prognostics (n=164). RNA was extracted from 500 microliter of maternal serum using the miRNeasy Micro kit (Qiagen). NEBNext Small RNAseq Library Preparation Kit was used for library construction.

  Study phs002016

• Large Scale Meta-analysis Characterizes Genetic Architecture for Common Psoriasis-associated Variants

  The genotypes obtained from the Affymetrix Biobank Plus array constituted one of eight Caucasian datasets used in a large genome-wide meta-analysis of the association of psoriasis cases versus unaffected controls. With a combined effective sample size of > 39,000 individuals, this study identified 16 new psoriasis loci achieving genome-wide significance, increasing the total number of identified psoriasis loci for European-ancestry populations to 63.

  Study phs001306

• T-bet+ CXCR3+ B cells drive hyperreactive B-T cell interactions in multiple sclerosis

  Data Access Committee means the following members of the Institute of Experimental Immunology, UZH, and investigators of the publication, to which the Data Access refers and who are responsible for making the data access decisions for the genotype and gene expression generated by UZH or respectively the epigenetic data, which had been generated at Karolinska Institute. Christian Münz, PhD; Co-Director of Institute of Experimental Immunology, University of Zurich Roland Martin, MD; Affiliated Group Leader (to Institute Münz) of Institute of Experimental Immunology Institute of Experimental Immunology Ivan Jelcic, PhD, Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland Maja Jagodic, PhD, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden

  Dac EGAC50000000464

• Long-read sequencing for cell-free DNA analysis (human)

  In this study, we compared the two long-read sequencing platforms, namely the single-molecule real-time sequencing by Pacific Biosciences and nanopore sequencing by Oxford Nanopore Technologies, for the analysis of cell-free DNA from plasma. Cell-free DNA from plasma samples of 31 pregnant women at different trimesters, 6 hepatitis B carriers, and 8 patients with hepatocellular carcinoma were sequenced with the two platforms.

  Study EGAS00001006328

• Whole exome sequencing data for patients with Bosma arhinia microphthalmia syndrome (BAMS).

  The datasets includes 21 samples from 7 families with Bosma arhinia microphthalmia (BAMS). For details of the study please refer to the manuscript "De novo mutations in SMCHD1 cause Bosma arhinia microphthalmia syndrome and abrogate nasal development", Nature Genetics 2017. Each sample was exome sequenced and the family ID in sample description refers to the Individual ID in Supplementary figure 2 of the manuscript.

  Study EGAS00001002193

• We evaluate the PGD/PGS including 129 couples with NGS test and 266 couples with SNP-array test for the detection of embryonic chromosomal abnormalities.

  A total of 395 couples were subjected to IVF-PGD treatment, including 129 couples with NGS test and 266 couples with SNP-array test for the detection of embryonic chromosomal abnormalities. The NGS test was performed using low coverage whole genome sequencing with HiSeq 2000 platform. And the SNP array test was using Affymetrix Gene Chip Mapping Nsp I 262K.

  Study EGAS00001000981